Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
BTKi has become the standard treatment regimen for CLL/SLL，there is a lack of large-scale real-world studies on the use status and related influencing factors of BTK inhibitors. Therefore, we plan to conduct this multicenter retrospective cross-sectional study to understand the current situation of BTK inhibitor treatment for CLL/SLL patients in China and the related influencing factors, and to explore more suitable treatment patterns based on this.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| BTK inhibitor treated | investigate the current situation of BTK inhibitor treatment for CLL/SLL patients in China and the related influencing factors, including the efficacy and safety, the drug swith between different BTKis，the BTKi based timed limited therapy, etc |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| BTK inhibitor | Drug | BTKi can refer to Orelabrutinib, Ibrutinib, Zanubrutinib, and Acalabrutinib |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patient characteristics of those receiving BTKi treatment | Describe the patient characteristics of those receiving BTKi treatment, including age, gender, etc | up to one year |
| Measure | Description | Time Frame |
|---|---|---|
| overall response rate | Assessed according to the iwCLL2018 criteria | up to one year |
| Incidence of adverse reactions | Assessed according to the CTCAE 5.0 criteria |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
CLL/SLL Patient who receiving BTKi treatment
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Huayuan Zhu, MD | Contact | 025-58530260 | huayuan.zhu@hotmail.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Haematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital | Recruiting | Nanjin | Jiangsu | 210029 | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| up to one year |